Review





Similar Products

tigit antibody, anti-human  (Miltenyi Biotec)
94
Miltenyi Biotec tigit antibody, anti-human
Tigit Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tigit antibody, anti-human/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
tigit antibody, anti-human - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
antibodies against tigit  (Proteintech)
94
Proteintech antibodies against tigit
Antibodies Against Tigit, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against tigit/product/Proteintech
Average 94 stars, based on 1 article reviews
antibodies against tigit - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
anti tigit antibody  (Bristol Myers)
86
Bristol Myers anti tigit antibody
Anti Tigit Antibody, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti tigit antibody/product/Bristol Myers
Average 86 stars, based on 1 article reviews
anti tigit antibody - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
tigit cd155  (Galectin Therapeutics)
86
Galectin Therapeutics tigit cd155
The interaction between CD4+/CD8+ T cells and antigen-presenting cells (APCs) or tumor cells is regulated by various immune checkpoints, such as the activating checkpoint CD226-CD155, and inhibitory checkpoints including <t>TIGIT-CD155,</t> Tim-3-Galectin-9, and PD1-PDL1. Activation of theseinhibitory checkpoints results in T cell exhaustion and/or functional impairment. Hyperthermia treatment has been shown to upregulate the expressionof TIGIT, Tim-3, and PD1 molecules on T cells, thereby enhancing their responsiveness to immune checkpoint blockade with monoclonal antibodies.
Tigit Cd155, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tigit cd155/product/Galectin Therapeutics
Average 86 stars, based on 1 article reviews
tigit cd155 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
anti human tigit mbsa43  (fluidigm)
93
fluidigm anti human tigit mbsa43
The interaction between CD4+/CD8+ T cells and antigen-presenting cells (APCs) or tumor cells is regulated by various immune checkpoints, such as the activating checkpoint CD226-CD155, and inhibitory checkpoints including <t>TIGIT-CD155,</t> Tim-3-Galectin-9, and PD1-PDL1. Activation of theseinhibitory checkpoints results in T cell exhaustion and/or functional impairment. Hyperthermia treatment has been shown to upregulate the expressionof TIGIT, Tim-3, and PD1 molecules on T cells, thereby enhancing their responsiveness to immune checkpoint blockade with monoclonal antibodies.
Anti Human Tigit Mbsa43, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human tigit mbsa43/product/fluidigm
Average 93 stars, based on 1 article reviews
anti human tigit mbsa43 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
3153019b  (fluidigm)
93
fluidigm 3153019b
The interaction between CD4+/CD8+ T cells and antigen-presenting cells (APCs) or tumor cells is regulated by various immune checkpoints, such as the activating checkpoint CD226-CD155, and inhibitory checkpoints including <t>TIGIT-CD155,</t> Tim-3-Galectin-9, and PD1-PDL1. Activation of theseinhibitory checkpoints results in T cell exhaustion and/or functional impairment. Hyperthermia treatment has been shown to upregulate the expressionof TIGIT, Tim-3, and PD1 molecules on T cells, thereby enhancing their responsiveness to immune checkpoint blockade with monoclonal antibodies.
3153019b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3153019b/product/fluidigm
Average 93 stars, based on 1 article reviews
3153019b - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
clone 1g9 cat  (Bio X Cell)
95
Bio X Cell clone 1g9 cat
The interaction between CD4+/CD8+ T cells and antigen-presenting cells (APCs) or tumor cells is regulated by various immune checkpoints, such as the activating checkpoint CD226-CD155, and inhibitory checkpoints including <t>TIGIT-CD155,</t> Tim-3-Galectin-9, and PD1-PDL1. Activation of theseinhibitory checkpoints results in T cell exhaustion and/or functional impairment. Hyperthermia treatment has been shown to upregulate the expressionof TIGIT, Tim-3, and PD1 molecules on T cells, thereby enhancing their responsiveness to immune checkpoint blockade with monoclonal antibodies.
Clone 1g9 Cat, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clone 1g9 cat/product/Bio X Cell
Average 95 stars, based on 1 article reviews
clone 1g9 cat - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
tigit targeting lentiviruses  (Angel Biotechnology)
86
Angel Biotechnology tigit targeting lentiviruses
The interaction between CD4+/CD8+ T cells and antigen-presenting cells (APCs) or tumor cells is regulated by various immune checkpoints, such as the activating checkpoint CD226-CD155, and inhibitory checkpoints including <t>TIGIT-CD155,</t> Tim-3-Galectin-9, and PD1-PDL1. Activation of theseinhibitory checkpoints results in T cell exhaustion and/or functional impairment. Hyperthermia treatment has been shown to upregulate the expressionof TIGIT, Tim-3, and PD1 molecules on T cells, thereby enhancing their responsiveness to immune checkpoint blockade with monoclonal antibodies.
Tigit Targeting Lentiviruses, supplied by Angel Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tigit targeting lentiviruses/product/Angel Biotechnology
Average 86 stars, based on 1 article reviews
tigit targeting lentiviruses - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
anti tigit antibody  (Bio X Cell)
95
Bio X Cell anti tigit antibody
The interaction between CD4+/CD8+ T cells and antigen-presenting cells (APCs) or tumor cells is regulated by various immune checkpoints, such as the activating checkpoint CD226-CD155, and inhibitory checkpoints including <t>TIGIT-CD155,</t> Tim-3-Galectin-9, and PD1-PDL1. Activation of theseinhibitory checkpoints results in T cell exhaustion and/or functional impairment. Hyperthermia treatment has been shown to upregulate the expressionof TIGIT, Tim-3, and PD1 molecules on T cells, thereby enhancing their responsiveness to immune checkpoint blockade with monoclonal antibodies.
Anti Tigit Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti tigit antibody/product/Bio X Cell
Average 95 stars, based on 1 article reviews
anti tigit antibody - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

Image Search Results


The interaction between CD4+/CD8+ T cells and antigen-presenting cells (APCs) or tumor cells is regulated by various immune checkpoints, such as the activating checkpoint CD226-CD155, and inhibitory checkpoints including TIGIT-CD155, Tim-3-Galectin-9, and PD1-PDL1. Activation of theseinhibitory checkpoints results in T cell exhaustion and/or functional impairment. Hyperthermia treatment has been shown to upregulate the expressionof TIGIT, Tim-3, and PD1 molecules on T cells, thereby enhancing their responsiveness to immune checkpoint blockade with monoclonal antibodies.

Journal: Frontiers in Immunology

Article Title: Recent advances in preclinical studies combining hyperthermia therapy with novel immune checkpoint targeting agents

doi: 10.3389/fimmu.2026.1722115

Figure Lengend Snippet: The interaction between CD4+/CD8+ T cells and antigen-presenting cells (APCs) or tumor cells is regulated by various immune checkpoints, such as the activating checkpoint CD226-CD155, and inhibitory checkpoints including TIGIT-CD155, Tim-3-Galectin-9, and PD1-PDL1. Activation of theseinhibitory checkpoints results in T cell exhaustion and/or functional impairment. Hyperthermia treatment has been shown to upregulate the expressionof TIGIT, Tim-3, and PD1 molecules on T cells, thereby enhancing their responsiveness to immune checkpoint blockade with monoclonal antibodies.

Article Snippet: The inhibitory checkpoints, including PD-1/PD-L1, CTLA-4/CD80/CD86, TIGIT/CD155, Tim-3/Galectin-9, CD47/SIRPα, LAG3/MHC, negatively regulate the activity of immune cells to avoid excessive response such as “cytokine storm”.

Techniques: Activation Assay, Functional Assay, Bioprocessing